{
    "nctId": "NCT02204462",
    "briefTitle": "FBnTP Imaging of Breast Cancer",
    "officialTitle": "FBnTP Positron Emission Mammography Imaging of Mitochondria Function - Breast Cancer",
    "overallStatus": "TERMINATED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE1",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 4,
    "primaryOutcomeMeasure": "Malignant breast cancer detection",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female patients with newly-diagnosed invasive and/or intraductal breast cancer detected by core needle or vacuum-assisted biopsy (i.e., index cancer)\n* Age \\> 25 Ability and willingness to sign informed consent prior to any study procedure.\n* Positive indication of disease on mammogram or MRI scan.\n* Candidate for breast cancer surgery on the basis of recommendation of a breast cancer surgeon.\n* Ability to undergo up to 90 minutes of PEM imaging.\n\nExclusion Criteria:\n\n* Any active or chronic illness that, in the opinion of the investigators, would make the study unsafe or limit compliance with study procedures.\n* Past or present history of active substance abuse (drug or alcohol).\n* Inability to tolerate venous access.\n* Pregnant females are excluded from this study. All females of child-bearing potential will undergo a serum pregnancy test within 48 hours prior to FBnTP administration.",
    "sex": "FEMALE",
    "minimumAge": "26 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}